Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
A grade PMID 42321916
View analysis →A grade PMID 42690647
View analysis →A grade PMID 42372741
View analysis →A grade PMID 42216567
View analysis →A grade PMID 41916649
View analysis →A grade PMID 42382416
View analysis →A grade PMID 42150584
View analysis →B grade PMID 42748428
View analysis →A grade PMID 41756844
View analysis →A grade PMID 42765973
View analysis →A grade PMID 42362103
View analysis →A grade PMID 42101908
View analysis →In a cross-sectional survey of 2,755 Chinese college students, the study identified two HPV vaccine-belief profiles and found that the lower-barrier, higher-benefit profile was associated with greater knowledge, e-health literacy, vaccination intention, and reported uptake.
The evidence shows associations between favorable vaccine beliefs, e-health literacy, and HPV vaccination uptake; it supports—but does not test—the hypothesis that targeted digital health education and barrier-reduction interventions could increase HPV vaccination and thereby contribute to long-term prevention of HPV-related cancers.
In a retrospective SEER cohort of 147 children with H3K27M-mutant DIPG, a four-variable nomogram predicted death within six months with an optimism-corrected C-index of 0.702, while non-receipt of radiotherapy was the only independently associated risk factor.
The evidence supports radiotherapy status as a prognostic correlate of six-month mortality, but it does not establish that radiotherapy itself causally prevents early death; inferentially, the model could help identify patients needing expedited evaluation, counseling, or trial consideration if externally validated.
This paper presents a multicountry implementation-research protocol for assessing whether health facilities can deliver concomitant HPV vaccination and HPV-based cervical screening to vulnerable adults aged 25–45 years.
The protocol provides no efficacy evidence; it hypothesizes that identifying and addressing health-system readiness gaps could enable integrated vaccination and screening, potentially improving cervical-cancer prevention among underserved populations.
This single-centre retrospective cohort of 52 children found substantial phenotypic overlap between infantile- and very-early-onset IBD, identified two monogenic disorders among 38 genotyped children with successful bone marrow transplantation, and noted early primary sclerosing cholangitis in 8%.
Evidence from this cohort links severe perianal infantile-onset IBD to two identified monogenic disorders treated successfully with bone marrow transplantation; as an inference requiring prospective validation, phenotype-guided genetic evaluation could identify a small subgroup for whom immune-directed definitive therapy may be appropriate.
In a retrospective Moroccan cohort of 106 children with acute leukemia, flow cytometry refined lineage classification, including reclassification of six MPO-negative suspected ALL cases and identification of biphenotypic acute leukemia.
The study provides evidence that adding flow cytometry to cytology and cytochemistry improves diagnostic classification in this resource-limited setting; it is reasonable but unproven to infer that more accurate lineage assignment could improve treatment selection and outcomes.
The paper reports a computational framework that learns clusters of related cancer subtypes while estimating subtype-specific gene regulatory networks, with synthetic-data validation and reported diagnostic improvements in pediatric and adult brain tumor transcriptomic datasets.
Evidence in the record supports improved transcriptomic subtype classification and interpretable network estimation, not treatment efficacy; inferentially, the identified subtype-specific networks could help generate therapeutic targets or treatment-selection biomarkers if independently validated biologically and clinically.
This narrative review summarizes evidence that testicular adrenal rest tumors can occur before puberty in boys with classic congenital adrenal hyperplasia and proposes risk-adapted, earlier ultrasound monitoring to help prevent delayed recognition of fertility-threatening gonadal injury.
The record supports an association of sustained ACTH excess and severe or poorly controlled congenital adrenal hyperplasia with TART risk; it is reasonable but unproven to hypothesize that earlier risk-based imaging, followed by appropriate disease-management decisions, could limit irreversible testicular damage and preserve fertility.
A nationally representative cross-sectional survey of 1,635 New Zealand adults found broad support for greater HPV-vaccination investment, single-dose vaccination, free cervical screening, targeted lung-cancer screening, and increased taxation for healthcare funding.
The evidence shows public acceptability of cancer-prevention and screening policies; it indirectly supports the hypothesis that implementing these policies—particularly adolescent HPV vaccination—could improve prevention uptake and reduce inequities, but the survey does not test implementation, vaccination or screening uptake, cancer incidence, safety, or clinical outcomes.
Using SEER data from 1,362 pediatric osteosarcoma patients diagnosed from 2004–2018, the study developed and internally validated a nomogram associating T stage, N stage, surgery, and radiotherapy with pulmonary metastasis status at diagnosis, with C-indexes of 0.699 and 0.736 in the training and validation cohorts.
The evidence supports an association-based risk-stratification model, not a treatment effect; it may be hypothesized that, after external prospective validation with appropriately timed imaging, pathology, molecular, and treatment data, such a model could help prioritize metastatic evaluation or clinical management, but improved outcomes are not demonstrated.
The study reports elevated circulating exosomal miR-22-3p in patients with endometriosis and cell-based evidence that it promotes endometrial epithelial proliferation, migration, and invasion by targeting and inhibiting p53.
The supplied evidence supports an exosomal miR-22-3p–p53 regulatory relationship in endometriosis; it remains an untested inference that inhibiting miR-22-3p could restore p53 activity, induce apoptosis, or reduce recurrence, and no pediatric-cancer therapeutic effect is demonstrated.
A provincial focus group used nominal-group and voting procedures to define an initial pediatric oncology symptom-screening program targeting newly diagnosed or relapsed outpatients receiving ambulatory chemotherapy, with weekly screening for three months and an option to continue.
The record establishes implementation parameters rather than testing a therapy or clinical benefit; it is reasonable to hypothesize that standardized routine screening could prompt earlier symptom management and improve quality of life, but no screening uptake, management changes, toxicity reduction, or patient outcomes are reported.
In a retrospective cohort of 208 cancer patients with febrile neutropenia, a stepwise carbapenem-sparing antibiotic protocol was associated with reported clinical improvement without first-line escalation for most patients, although its simulated pathogen coverage was lower than that of broader regimens and pediatric patients were excluded.
The record supports the feasibility of a carbapenem-sparing, stepwise empiric strategy in this adult tertiary-center cohort; it may reduce unnecessary broad-spectrum antibiotic exposure while retaining clinical effectiveness, but pediatric efficacy, comparative benefit, safety, and resistance effects remain untested in the supplied evidence.
